2021년 Vol.38 No.02
Background : It is necessary to systematically assess the appropriateness of the relative value for the hospital pharmacist’s service, which has never been revised since the introduction of the relative value of system in 2001.
Methods : In this study, we surveyed the time spent and the relative value of workload for each service conducted by hospital pharmacists which are currently included in the list of National Health Insurance (NHI) benefits, and we also investigated the which services should be newly included in the NHI list.
Results : Among 240 hospitals, 51 hospitals responded to the survey and the estimated relative values for 1-day dispensing were similar regardless of the patient setting (inpatient, outpatient, or discharged patient). The relative values for ‘aseptic compounding for chemotherapy’, ‘aseptic compounding for total parenteral nutrition’, ‘aseptic compounding for other injectables’, ‘nutrition support team consult’, ‘counseling for discharge medication’, ‘discharge medication reconciliation’ ‘counseling for optimal inhaler use’, ‘anticoagulation management services’, ‘transplant pharmaceutical care’, and ‘critical care pharmacy service’ were 2.8~38.2 times higher compared to that for ‘1-day dispensing for an inpatient.’ It was shown that ‘critical care pharmacy service’, ‘medication counseling to a discharged patient’, and ‘counseling for optimal inhaler use’ had priority in the NHI benefits listing.
Conclusion : This study discovered a gap between the measured relative values reflecting actual workload and currently applied reimbursement, and identified which services have priority in NHI benefits listing. We hope that these results would help adjust the NHI insurance fees to reduce the gap and establish new fees for advanced clinical services.